MX2021011589A - Composición anestésica y método para anestesiar el ojo. - Google Patents

Composición anestésica y método para anestesiar el ojo.

Info

Publication number
MX2021011589A
MX2021011589A MX2021011589A MX2021011589A MX2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A MX 2021011589 A MX2021011589 A MX 2021011589A
Authority
MX
Mexico
Prior art keywords
articaine
eye
anesthetic
formulation
amount
Prior art date
Application number
MX2021011589A
Other languages
English (en)
Spanish (es)
Inventor
Martin Uram
Original Assignee
Martin Uram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/024239 external-priority patent/WO2019191200A1/en
Application filed by Martin Uram filed Critical Martin Uram
Publication of MX2021011589A publication Critical patent/MX2021011589A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2021011589A 2019-03-26 2020-03-16 Composición anestésica y método para anestesiar el ojo. MX2021011589A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962824207P 2019-03-26 2019-03-26
PCT/US2019/024239 WO2019191200A1 (en) 2018-03-27 2019-03-27 Method and formulation for producing anesthesia of internal aspect of eye wall by topical application
US16/811,798 US11096922B2 (en) 2018-03-27 2020-03-06 Anesthetic composition and method of anesthetizing the eye
PCT/US2020/022915 WO2020197816A1 (en) 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye

Publications (1)

Publication Number Publication Date
MX2021011589A true MX2021011589A (es) 2021-12-15

Family

ID=72609654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011589A MX2021011589A (es) 2019-03-26 2020-03-16 Composición anestésica y método para anestesiar el ojo.

Country Status (11)

Country Link
EP (1) EP3946311A4 (zh)
JP (1) JP2022527621A (zh)
KR (1) KR20210143254A (zh)
CN (1) CN114072139A (zh)
AU (1) AU2020245203A1 (zh)
BR (1) BR112021019039A2 (zh)
CA (1) CA3134531A1 (zh)
IL (1) IL286624A (zh)
MX (1) MX2021011589A (zh)
SG (1) SG11202110423UA (zh)
WO (1) WO2020197816A1 (zh)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333850T3 (de) * 1992-05-06 2011-03-17 Alcon Laboratories, Inc., Fort Worth Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
ES2383003T3 (es) * 2001-11-21 2012-06-15 Carl Zeiss Meditec Sas Composición para estabilizar ácido hialurónico
CN101695488B (zh) * 2009-11-05 2012-05-02 蚌埠丰原涂山制药有限公司 复方阿替卡因注射用冻干制剂及其制备方法
CN101721407B (zh) * 2009-11-23 2013-04-10 蚌埠丰原涂山制药有限公司 复方盐酸阿替卡因注射液及其制备方法
FR2968996B1 (fr) * 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
FR3036035B1 (fr) * 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
JP2018526423A (ja) * 2015-09-08 2018-09-13 ビューポイント セラピューティクス， インコーポレイテッド 眼科疾患を処置するための化合物および製剤
WO2018220283A1 (fr) * 2017-05-29 2018-12-06 Kh Medtech Sarl Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine

Also Published As

Publication number Publication date
CA3134531A1 (en) 2020-10-01
IL286624A (en) 2021-10-31
WO2020197816A1 (en) 2020-10-01
EP3946311A4 (en) 2022-12-28
SG11202110423UA (en) 2021-10-28
AU2020245203A1 (en) 2021-11-11
BR112021019039A2 (pt) 2021-11-30
JP2022527621A (ja) 2022-06-02
EP3946311A1 (en) 2022-02-09
CN114072139A (zh) 2022-02-18
KR20210143254A (ko) 2021-11-26

Similar Documents

Publication Publication Date Title
NZ603345A (en) Stabilized ophthalmic galactomannan formulations
EA025026B1 (ru) Система подачи невязкого полимерного раствора на основе простагландина, не содержащего консервант
BR112015019657A8 (pt) composições tópicas, kit e método para aumentar a liberação de óxido nítrico a partir de um gel tópico anidro contendo uma macromolécula modificada de diazeniodiolato
RU2010142353A (ru) Водные фармацевтические композиции, содержащие борат-полиольные комплексы
MX2013011314A (es) Tratamientos oftalmicos.
BR112014009131A8 (pt) formulações de etanercept estabilizadas com meglumina
MX2015015356A (es) Formulacion estabilizada de pemetrexed.
EA202091755A1 (ru) Композиции гиалуроновой кислоты, включающие мепивакаин
PH12016502100A1 (en) Liquid formulation comprising gm-csf neutralizing compound
MX2019003520A (es) Mezclas y formulacions que comprenden una sal de alquil amonio de acido etilendiaminotetraacetico (edta).
MX2023009052A (es) Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo.
MX2021011589A (es) Composición anestésica y método para anestesiar el ojo.
BR112015006464A2 (pt) composição farmacêutica compreendendo rebamipida
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
TW201309306A (zh) 含有玻尿酸或其鹽及丙二醇之點眼液
JP5922609B2 (ja) ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性組成物
MX2016008546A (es) Reduccion de queloides utilizando alantoina topica.
CN102215819B (zh) 具有相对低的离子强度的药物组合物
MX2022011565A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
RU2014101995A (ru) Антипаразитарная композиция, содержащая макроциклический лактон и левамизол, и способ лечения паразитарной инфестации
JP2017165729A (ja) メグルミン又はその塩からなる防腐剤
BR112014013564A8 (pt) composição farmacêutica tópica destinada à aplicação ao olho, ouvido ou nariz
WO2015046281A1 (ja) 安定化された２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物
PL434409A1 (pl) Zastosowanie kompozycji alkaloidów protoberberynowych jako środka antybakteryjnego i antygrzybicznego do stabilizacji kolagenu rybiego oraz sposób stabilizacji kolagenu rybiego
PH12016500932B1 (en) Method of treating ocular disorders